Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pediatr Adolesc Gynecol ; 31(2): 153-155, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28993226

RESUMO

BACKGROUND: Langerhans cell histiocytosis (LCH) is a rare localized or systemic disease characterized by proliferation of myeloid-derived dendritic cells. Vulvar lesions might be the herald symptom of LCH and might mimic other cutaneous lesions. Prognosis varies widely on the basis of the extent and spread of disease. CASE: An 8-year-old girl with a 4-month history of vulvar lesions resistant to topical steroids was referred by her pediatrician. Vulvar biopsy was diagnostic for LCH. Imaging studies revealed a left hip lesion consistent with LCH. The patient was subsequently treated for multisystem LCH with vinblastine and prednisone. SUMMARY AND CONCLUSION: Although rare, LCH might be diagnosed by gynecologic providers and should be included in the differential diagnosis of genital lesions. We recommend having a low threshold for performing biopsy of vulvar lesions.


Assuntos
Histiocitose de Células de Langerhans/complicações , Doenças da Vulva/etiologia , Criança , Feminino , Glucocorticoides/uso terapêutico , Humanos , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Prednisona/uso terapêutico , Moduladores de Tubulina/uso terapêutico , Vimblastina/uso terapêutico , Doenças da Vulva/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...